3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Promyelocytic, Acute
4
Leukemia
3
Neuroblastoma
2
Multiple Myeloma
2
Leukemia, Myeloid, Acute
2
Wilms Tumor
1
Testicular Neoplasms
1
Teratoma
1
Skin Neoplasms
1
Sarcoma
1
Retinoblastoma
1
Recurrence
1
Ovarian Neoplasms
1
Ovarian Germ Cell Cancer
1
Osteosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Kidney Neoplasms
1
Hepatoblastoma
1
Endometrial Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Childhood Acute Promyelocytic Leukemia With PML-RARA
1
Central Nervous System Neoplasms
1
Carcinoma, Small Cell
1
Interventions
Temozolomide
115
Bevacizumab
72
Radiotherapy
52
Radiation
23
Erlotinib Hydrochloride
13
Lomustine
12
pembrolizumab
11
Magnetic Resonance Spectroscopy
11
Vorinostat
10
Nivolumab
10
Surgical Procedures, Operative
9
Irinotecan
9
Sorafenib
8
Radiotherapy, Intensity-Modulated
8
Radiotherapy, Conformal
7
Immunoglobulin G
7
Everolimus
7
Drug Therapy
7
Disulfides
7
Radiosurgery
6
Granulocyte-Macrophage Colony-Stimulating Factor
6
Carmustine
6
antineoplaston AS 2-1
5
antineoplaston A10
5
Sirolimus
5
Cilengitide
5
veliparib
4
veledimex
4
temsirolimus
4
selinexor
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Glioblastoma
×
Arsenic Trioxide
×
Clear all
No trials found.